Being a Parkinson's disease sufferer, and previously having prostate cancer, Andrew Grove knows all to well the ins and outs of hospital life. That's partly why the ex-CEO and chairman of Intel has pumped money into "translational medicine" research. »5/18/10 6:22am 5/18/10 6:22am
Kinja is in read-only mode. We are working to restore service.